My account
Injectables Orals Peptides Human Growth Hormone SARMs
Sign in
A
Anastrozole
B
Bacteriostatic water Boldenone undecylenate
C
Clenbuterol Clomiphene citrate Cabergoline
D
Drostanolone enanthate Drostanolone propionate Dehydroepiandrosterone (DHEA)
E
Erythropoietin Exemestane
F
Fluoxymesterone
H
Human chorionic gonadotropin Human growth hormone
L
Liothyronine sodium
M
Mecasermin Meldonium Mesterolone Methandienone Methenolone acetate Methenolone enanthate Melanotan-2
N
Nandrolone decanoate Nandrolone phenylpropionate
O
Oxandrolone Oxymetholone
S
Sildenafil citrate Stanozolol
T
Trenbolone enanthate Trestolone acetate Trenbolone acetate Testosterone undecanoate Testosterone propionate Testosterone base and suspension Tadalafil citrate Testosterone cypionate Testosterone enanthate Tamoxifen citrate Turinabol
Y
Yohimbine
Show 164 results
Manufacturers
Categories
Substances
Disagree
Home Driada Medical Driada Medical
Tirzepatide
Tirzepatide - Driada Medical

Tirzepatide - Driada Medical

Brand:
Driada Medical
Category:
Peptides
Substance:
Tirzepatide
Package:
5 mg
Price:
0
See options
Product Overview

Tirzepatide (Mounjaro®) has introduced a groundbreaking dual GIP/GLP-1 receptor approach for Type 2 Diabetes (T2D), offering significant advances in glycemic and weight management. Approved in 2022, it goes beyond standard GLP-1 agonists with notable reductions in HbA1c and body weight. The SURPASS-4 trial showed additional benefits, with lower mortality versus insulin glargine, reinforcing its value in T2D care. Tirzepatide’s safety and potential applications in obesity make it a transformative option in metabolic health, signaling a shift in diabetes treatments and future possibilities.

References:

Gallwitz, B., 2022. Clinical perspectives on the use of the GIP/GLP-1 receptor agonist tirzepatide for the treatment of type-2 diabetes and obesity. Frontiers in Endocrinology.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Tirzepatide by Driada Medical, consult with your doctor or healthcare professional.

Explore More Products
Reviews
Leave Review
FAQ
How does Tirzepatide affect appetite?
Its GLP-1 agonism helps suppress appetite, aiding in weight loss.
References:

Gallwitz, B., 2022. Clinical perspectives on the use of the GIP/GLP-1 receptor agonist tirzepatide for the treatment of type-2 diabetes and obesity. Frontiers in Endocrinology.

Is Tirzepatide effective for people with severe diabetes?
Clinical studies have shown positive results across various T2D severity levels, but patient response may vary.
References:

Gallwitz, B., 2022. Clinical perspectives on the use of the GIP/GLP-1 receptor agonist tirzepatide for the treatment of type-2 diabetes and obesity. Frontiers in Endocrinology.

What other metabolic conditions could Tirzepatide treat?
It may be studied for conditions like obesity and metabolic syndrome, given its effects on weight and glycemic control.
References:

Gallwitz, B., 2022. Clinical perspectives on the use of the GIP/GLP-1 receptor agonist tirzepatide for the treatment of type-2 diabetes and obesity. Frontiers in Endocrinology.